Source: Reuters

Ab Initio: BRIEF-Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies

* Ab Initio - addition of will somers, ph.d., vice president of biomedicines design at pfizer, to ab initio scientific advisory board

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
CEO Avatar

Founder & CEO

Sheryl Handler

CEO Approval Rating

59/100

Ab Initio is an enterprise software firm that specializes in data processing applications and enterprise application integration. Read more